跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RISPERIDONE-CHANELLE ORAL SOLUTION 1 MG/ML - HSA Drug Approval Details
Approvals
/
HSA
/
RISPERIDONE-CHANELLE ORAL SOLUTION 1 MG/ML
Approved
THERAPEUTIC
RISPERIDONE-CHANELLE ORAL SOLUTION 1 MG/ML
Dar Al Dawa Development and Investment Co Ltd
🇸🇬 Health Sciences Authority
Approval Date
Apr 26, 2017
Approval ID
5ba91601aa9e038b
Company
Dar Al Dawa Development and Investment Co Ltd
Type
Therapeutic
Approval Details
Approval Id
5ba91601aa9e038b
Drug Name
RISPERIDONE-CHANELLE ORAL SOLUTION 1 MG/ML
Product Name
RISPERIDONE-CHANELLE ORAL SOLUTION 1 MG/ML
Approval Number
SIN15227P
Approval Date
2017-04-26
Registrant
MEDICELL PHARMACEUTICAL (S) PTE. LTD.
Licence Holder
MEDICELL PHARMACEUTICAL (S) PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
SOLUTION
Route Of Administration
ORAL
Atc Code
N05AX08
Atc Item Name
risperidone
Pharma Manufacturer Name
MEDICELL PHARMACEUTICAL (S) PTE. LTD.
Company Detail Path
/organization/medicell-pharmaceutical-s-pte-ltd
Active Ingredients
RISPERIDONE
1mg/ml
RISPERIDONE
1 MG/ML
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Apr 26, 2017
Approval ID
5ba91601aa9e038b
Type
Therapeutic
Back to HSA Approvals
